标题
Selective and noncovalent targeting of RAS mutants for inhibition and degradation
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-11
DOI
10.1038/s41467-021-22969-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
- (2020) Jenny Y. Xue et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- RAS-targeted therapies: is the undruggable drugged?
- (2020) Amanda R. Moore et al. NATURE REVIEWS DRUG DISCOVERY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface
- (2020) Uddhav K. Shigdel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
- (2020) Nicolas Bery et al. Nature Communications
- Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs
- (2020) Michael J. Bond et al. ACS Central Science
- Cytosolic delivery of proteins by cholesterol tagging
- (2020) Wanyi Tai et al. Science Advances
- GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf
- (2020) Ziyang Zhang et al. ACS Central Science
- Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States
- (2020) Shuhui Lim et al. ACS Central Science
- A Rational Approach for Creating Peptides Mimicking Antibody Binding
- (2019) Sameer Sachdeva et al. Scientific Reports
- Targeted Protein Degradation through Cytosolic Delivery of Monobody Binders Using Bacterial Toxins
- (2019) Nadine Eliane Schmit et al. ACS Chemical Biology
- Allosteric modulation of a human protein kinase with monobodies
- (2019) Adelajda Zorba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drugging an undruggable pocket on KRAS
- (2019) Dirk Kessler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
- (2019) Jill Hallin et al. Cancer Discovery
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- Engineered protein scaffolds as leads for synthetic inhibitors of protein–protein interactions
- (2018) Michael G Wuo et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- A Raf-Competitive K-Ras Binder Can Fail to Functionally Antagonize Signaling
- (2018) Monique J. Kauke et al. MOLECULAR CANCER THERAPEUTICS
- Facile target validation in an animal model with intracellularly expressed monobodies
- (2018) Ankit Gupta et al. Nature Chemical Biology
- K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D
- (2018) Jillian A. Parker et al. STRUCTURE
- Targeting the α4–α5 dimerization interface of K-RAS inhibits tumor formation in vivo
- (2018) Imran Khan et al. ONCOGENE
- RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins
- (2017) Mehmet Cetin et al. JOURNAL OF MOLECULAR BIOLOGY
- Selective targeting of point-mutated KRAS through artificial microRNAs
- (2017) Mario Acunzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An engineered protein antagonist of K-Ras/B-Raf interaction
- (2017) Monique J. Kauke et al. Scientific Reports
- Inhibition of RAS function through targeting an allosteric regulatory site
- (2016) Russell Spencer-Smith et al. Nature Chemical Biology
- Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
- (2016) P. Lito et al. SCIENCE
- Molecular Mechanism for Conformational Dynamics of Ras·GTP Elucidated from In-Situ Structural Transition in Crystal
- (2016) Shigeyuki Matsumoto et al. Scientific Reports
- Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation
- (2016) Xuben Hou et al. Scientific Reports
- An affinity-directed protein missile system for targeted proteolysis
- (2016) Luke J. Fulcher et al. Open Biology
- AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein–Protein Interaction Interfaces
- (2015) David Rooklin et al. Journal of Chemical Information and Modeling
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
- (2015) Susan K. Fetics et al. STRUCTURE
- Absolute Quantification of Endogenous Ras Isoform Abundance
- (2015) Craig J. Mageean et al. PLoS One
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- ThePDB_REDOserver for macromolecular structure model optimization
- (2014) Robbie P. Joosten et al. IUCrJ
- PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
- (2013) Daniel R. Roe et al. Journal of Chemical Theory and Computation
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
- (2013) Romelia Salomon-Ferrer et al. Journal of Chemical Theory and Computation
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains
- (2013) F. Sha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NMR-based functional profiling of RASopathies and oncogenic RAS mutations
- (2013) M. J. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Towards automated crystallographic structure refinement withphenix.refine
- (2012) Pavel V. Afonine et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
- (2012) Andreas W. Götz et al. Journal of Chemical Theory and Computation
- Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy
- (2011) Satu Oltedal et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Teaching an Old Scaffold New Tricks: Monobodies Constructed Using Alternative Surfaces of the FN3 Scaffold
- (2011) Akiko Koide et al. JOURNAL OF MOLECULAR BIOLOGY
- Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
- (2011) N. Sunaga et al. MOLECULAR CANCER THERAPEUTICS
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- SAINT: probabilistic scoring of affinity purification–mass spectrometry data
- (2010) Hyungwon Choi et al. NATURE METHODS
- A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
- (2010) John Wojcik et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Design of protein function leaps by directed domain interface evolution
- (2008) J. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now